Efficacy, Adverse Events, and Inter-Drug Comparison of Mepolizumab and Reslizumab Anti-Il-5 Treatments of Severe Asthma – A Systematic Review and Meta-Analysis
European Clinical Respiratory Journal
doi 10.1080/20018525.2018.1536097
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
Informa UK Limited